Anti-TNF-α treatment for pelvic pain associated with endometriosis

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Lu, Donghao ^a   Song, Huan ^a   Shi, Gang ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; IBUPROFEN; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR INHIBITOR; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE EVENT; BIBEROGLU BEHRMAN SCORE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PELVIC DISEASE; PELVIC PAIN; PELVIC TENDERNESS; PELVIS SURGERY; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; DRUG ANTAGONISM; FEMALE; PELVIS PAIN SYNDROME;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ENDOMETRIOSIS; FEMALE; HUMANS; PELVIC PAIN; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84880060150     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008088.pub3     Document Type: Review

References (52)

1. Koninckx PR, Craessaerts M, Timmerman D, Cornillie F, Kennedy S. Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Human Reproduction 2008;23(9):2017-23.
2. Lian F, Li XL, Sun ZG, Zhang JW, Liu YH, Ma FM. Effect of Quyu Jiedu granule on microenvironment of ova in patients with endometriosis. Chinese Journal of Integrative Medicine 2009;15(1):42-6.
3. Anaf V, Chapron C, El Nakadi I, De Moor V, Simonart T, Noel JC. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertility and Sterility 2006;86:1336-43.
4. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertility and Sterility 1997;67:817-21.
5. Balasch J, Creus M, Fabregues F, Carmona F, Martinez-Roman S, Manau D, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Human Reproduction 1997;12:2046-50.
6. Barrier BF, Bates GW, Leland MM, Leach DA, Robinson RD, Propst MA. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertility and Sterility 2004;81 Suppl 1:775-9.
7. Berkkanoglu M, Arici A. Immunology and endometriosis. American Journal of Reproductive Immunology 2003;50(1):48-59.
8. Braun DP, Dmowski WP. Endometriosis: abnormal endometrium and dysfunctional immune response. Current Opinion in Obstetrics and Gynecology 1998;10:365-9.
9. Braun DP, Ding J, Dmowski WP. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertility and Sterility 2002;78:727-32.
10. Brosens IA. Endometriosis - a disease because it is characterized by bleeding. American Journal of Obstetrics and Gynecology 1997;176:263-7.
11. Bullimore DW. Endometriosis is sustained by tumour necrosis factor-alpha. Medical Hypotheses 2003;60(1):84-8.
12. Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treatment. Drugs 2001;61:1735-50.
13. Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. European Journal of Contraception and Reproductive Health Care 2007;12:194-202.
14. D'Antonio M, Martelli F, Peano S, Papoian R, Borrelli F. Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally induced endometriosis in rats. Journal of Reproductive Immunology 2000;48:81-98.
15. D'Hooghe TM, Cuneo S, Nugent N, Chai D, Deer F, Mwenda J. Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo and drug-controlled study. Fertility and Sterility 2001;76 Suppl 1:1.
16. D'Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Human Reproduction Update 2002;8(1):84-8.
17. D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: is the relationship resolved?. Seminars in Reproductive Medicine 2003;21:243-54.
18. Davis LJ, Kennedy SS, Moore J, Prentice A. Oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD001019.pub2]
19. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
20. Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertility and Sterility 1988;50:573-9.
21. Falconer H, Mwenda JM, Chai DC, Wagner C, Cornillie FJ, D'Hooghe TM. Treatment with anti-TNF antibody c5N reduces the extent of induced endometriosis in the baboon. Fertility and Sterility 2004;82 Suppl 2:54-5.
22. Falconer H, Mwenda JM, Chai DC, Song XR, Cornillie FJ, Bergqvist A, et al. Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis. Fertility and Sterility 2008;89(5):1537-45.
23. Farquhar C. Endometriosis. BMJ 2007;334:249-53.
24. Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. American Journal of Obstetrics and Gynecology 1984;148:85-90.
25. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane-handbook.org.
26. Ingelmo JM, Quereda F, Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in murine model. Fertility and Sterility 1999;71:907-11.
27. Iwabe T, Harada T, Tsudo T, Nagano Y, Yoshida S, Tanikawa M, et al. Tumor necrosis factor-alpha promote proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. Journal of Clinical Endocrinology and Metabolism 2000;85:824-9.
28. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. American Journal of Reproductive Immunology 1995;34:381-5.
29. Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR, Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with immune modulators loxoribine and levamisole. Fertility and Sterility 2000;72:135-41.
30. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Duselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction 2005;20(10):2698-704.
31. Kyama CM, Overbergh L, Mihalyi A, Cuneo S, Chai D, Debrock S, et al. Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. Fertility and Sterility 2008;89 Suppl 5:1306-13.
32. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertility and Sterility 2001;75(1):1-10.
33. Lee GH, Choi YM, Kim SH, Hong MA, Oh ST, Lim YT, et al. Association of tumor necrosis factor-a gene polymorphisms with advanced stage endometriosis. Human Reproduction 2008;23(4):977-81.
34. Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstetrics and Gynecology 1999;37:51-8.
35. Olive DL, Pritts EA. Treatment of endometriosis. New England Journal of Medicine 2003;345(4):266-75.
36. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertility and Sterility 1991;56:45-51.
37. Oosterlynck DJ, Meuleman C, Sobis H, Vandeputte M, Koninckx PR. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertility and Sterility 1993;59:778-82.
38. Possover M, Chiantera V. Isolated infiltrative endometriosis of the sciatic nerve: a report of three patients. Fertility and Sterility 2007;87:417-9.
39. Prentice A, Deary A, Goldbeck-Wood S, Farquhar CM, Smith S. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD000346.pub2]
40. Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD002122]
41. Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and management of endometriosis. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG) 2006.
42. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
43. Ridder LD, Benninga MA, Tamminiau JA, Hommes DW, Deventer SJ. Infliximab use in children and adolescents with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2007;45:3-14.
44. Robert R, Prat-Pradal D, Labat JJ, Bensignor M, Raoul S, Rebai R, et al. Anatomic basis of chronic perineal pain: role of the pudendal nerve. Radiologic Anatomy 1998;20:93-8.
45. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000068.pub2]
46. Siristatidis C, Nissotakis C, Chrelias C, Iacovidou H, Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. Journal of Obstetrics and Gynaecology Research 2006;32(2):162-70.
47. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 ina murine model of endometriosis. Human Reproduction 1999;14:2944-50.
48. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF. Angiogenesis and macrophage activation in endometriosis. Annals of the New York Academy of Sciences 1997;828:194-207.
49. Teramoto M, Kitawaki J, Koshiba H, Kitaoka Y, Obayashi H, Hasegawa G, et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. American Journal of Reproductive Immunology 2004;51:352-7.
50. Viganò P, Mangioni S, Odorizzi MP, Chiodini A, Rocca S, Chiodo I. Use of estrogen antagonists and aromatase inhibitors in endometriosis. Current Opinion in Investigational Drugs 2003;4:1209-12.
51. Winkel CA. A cost-effective approach to the management of endometriosis. Current Opinion in Obstetrics and Gynecology 2000;12:317-20.
52. Winkel CA. Evaluation and management of women with endometriosis. Obstetrics and Gynecology 2003;102:397-408.